phase ii trial - Robuta Search

https://www.cms.gov/medicare/coverage/ide/approved-ide-studies-items/g150275-nct02743078 Phase II Trial Of Optune Plus Bevacizumab In Bevacizumab-Refractory Recurrent Glioblastoma | CMS phase ii trial https://www.mendeley.com/catalogue/ca1f6d58-c187-3e11-bfda-55e6f8711741/ A phase II trial (ago 2.11) in pl... preview & related info | Mendeley (2012) Baumann et al. Annals of Oncology. Background: Recurrent platinum-resistant ovarian cancer usually has a poor outcome with conventional chemotherapeutic... phase ii trial https://www.dana-farber.org/clinical-trials/21-007 B- PRISM (Precision Intervention Smoldering Myeloma): A Phase II Trial of Combination of... The purpose of this research study is to learn whether the combination of daratumumab SC ( Darzalex Faspro), lenalidomide (Revlimid), bortezomib (Velcade) and... phase ii trial smoldering myeloma https://www.business-standard.com/article/health/coronavirus-vaccine-update-latest-news-on-corona-drug-vaccine-current-status-india-china-oxford-moderna-120070700574_1.html Coronavirus vaccine update: China's Zhifei starts Phase II trial of vaccine | Health News -... Coronavirus vaccine latest update: Moderna, AstraZeneca, BioNTech, Novavax, Sinovac and CanSino Biologics are among those leading the fight against... phase ii trial https://cancer.ca/en/cancer-information/resources/glossary/p/phase-ii-trial phase II trial | Canadian Cancer Society The second step in a clinical trial in which researchers determine if a new treatment works for a specific type of disease (such as cancer) and continues to... phase ii trial canadian cancer society https://www.mdanderson.org/newsroom/archived-news/vaccine-extends-glioblastoma-patients--survival-in-phase-ii-tria.h00-158596890.html ARCHIVED: Vaccine Extends Glioblastoma Patients' Survival in Phase II Trial | UT MD Anderson phase ii trial https://www.mdanderson.org/patients-family/diagnosis-treatment/clinical-trials/clinical-trials-index/clinical-trials-detail.ID2019-0715.html Phase II Trial of Treatment for IDH wildtype, non-histological Glioblastoma, Gliomas or Molecular... This phase II trial studies how well temozolomide and radiation therapy work in treating patients with IDH wildtype historically lower grade gliomas or... phase ii trial https://www.sciencedaily.com/releases/2013/10/131025135257.htm New ALS drug headed for phase II trial | ScienceDaily Researchers will soon begin phase IIa clinical trials of TDI-132, a drug that in animal models has shown promise in reducing the inflammation associated with... phase ii trial new als drug headed https://www.yalemedicine.org/clinical-trials/vismodegib-and-fak-inhibitor-gsk2256098-in-treating-patients-with-progressive-meningiomas Phase II Trial of SMO/ AKT/ NF2/CDK Inhibitors in Progressive Meningiomas With SMO/ AKT/ NF2/CDK... This phase II trial studies how well vismodegib, focal adhesion kinase (FAK) inhibitor GSK2256098, and capivasertib work in treating patients with meningioma... phase ii trial https://www.marketscreener.com/news/phase-ii-trial-failure-for-ipsen-in-fop-ce7d50ddd88af726 Phase II Trial Failure for Ipsen in FOP | MarketScreener Dec 19, 2025 - Ipsen has reported the failure of its pivotal phase II FALKON trial, which evaluated its investigational drug fidrisertib in patients with the ultra-rare bone... phase ii trial failure ipsen fop marketscreener https://www.biospace.com/nantkwest-announces-launch-of-merkel-cell-carcinoma-phase-ii-trial-deploying-novel-triple-combination-of-off-the-shelf-natural-killer-hank-cell-therapy-with-superagonist-il-15-cytokine-therapy-and-pd-l1-checkpoint-inhibitor-therapy NantKwest Announces Launch of Merkel Cell Carcinoma Phase II Trial Deploying Novel Triple... Jan 9, 2019 - NantKwest Inc. (Nasdaq:NK), a leading, clinical-stage, natural killer cell based therapeutics company, today announced the launch of a novel triple... merkel cell carcinoma phase ii trial https://www.mayo.edu/research/clinical-trials/cls-20147457?&p=1 Phase I/II Trial To Investigate BI 836858 In Myelodysplastic Syndromes - Mayo Clinic https://www.biospace.com/levicept-announces-positive-results-of-phase-ii-trial-of-novel-neurotrophin-3-inhibitor-levi-04-for-the-treatment-of-patients-with-moderate-to-severe-osteoarthritis Levicept Announces Positive Results of Phase II Trial of novel Neurotrophin-3 Inhibitor, LEVI-04,... https://www.biospace.com/effector-initiates-dosing-in-phase-ii-combination-trial-of-eft508-and-avelumab-in-microsatellite-stable-colorectal-cancer eFFECTOR Initiates Dosing In Phase II Combination Trial Of Eft508 And Avelumab In Microsatellite... https://www.hss.edu/research/clinical-trials/rituximab-scleroderma-pah-sclerosis-pulmonary-arterial-hypertension-inactive ASCI: A Randomized, Double-blind, Placebo-controlled, Phase II Multicenter Trial of a Monoclonal... https://www.prnewswire.com/news-releases/stemline-therapeutics-inc-announces-oral-presentation-of-positive-phase-iii-trial-results-with-novel-brain-cancer-vaccine-at-the-american-society-of-clinical-oncology-asco-2011-annual-meeting-123217013.html Stemline Therapeutics, Inc. Announces Oral Presentation of Positive Phase I/II Trial Results with... /PRNewswire/ -- Stemline Therapeutics, Inc. today announced that clinical results from a multi-epitope brain cancer vaccine, that Stemline has licensed from... https://investingnews.com/alzamend-neuro-reports-encouraging-pharmacodynamic-data-from-phase-ii-clinical-trial-of-al001-lithium-in-brain-study-in-a-trial-conducted-at-massachusetts-general-hospital/ Alzamend Neuro Reports Encouraging Pharmacodynamic Data from Phase II Clinical Trial of AL001... Apr 7, 2026 - Potentially Distinct Brain Profile: Across multiple brain regions, AL001 and lithium carbonate appeared to trend in opposite directions in brain chemistry... phase ii clinical trial https://www.biospace.com/press-releases/alzamend-neuro-announces-initiation-date-of-phase-ii-clinical-trial-of-al001-for-treatment-of-bipolar-disorder-to-take-place-at-massachusetts-general-hospital Alzamend Neuro Announces Initiation Date of Phase II Clinical Trial of AL001 for Treatment of... phase ii clinical trial https://menafn.com/1109431943/ORYZON-Announces-First-Patient-Dosed-In-NCI-Sponsored-Phase-III-Clinical-Trial-Of-Iadademstat-Plus-Immune-Checkpoint-Inhibitors-In-1L-Extensive-Stage-Small-Cell-Lung-Cancer ORYZON Announces First Patient Dosed In NCI-Sponsored Phase I/II Clinical Trial Of Iadademstat Plus... ORYZON Announces First Patient Dosed In NCI-Sponsored Phase I/II Clinical Trial Of Iadademstat Plus Immune Checkpoint Inhibitors In 1L Extensive Stage Small... https://www.southampton.ac.uk/research/projects/a-phase-i-ii-feasibility-trial-of-cancer-carer-medicines-management-ccmm-an A Phase I-II feasibility trial of Cancer Carer Medicines Management (CCMM): an educational... A Phase I-II feasibility trial of Cancer Carer Medicines Management (CCMM): an educational intervention for carer management of pain medication in cancer... https://www.prweb.com/releases/intrinsic_imaging_awarded_international_phase_ii_clinical_trial_for_chronic_iron_overload/prweb10968852.htm Intrinsic Imaging Awarded International Phase II Clinical Trial for Chronic Iron Overload Boston, MA, San Antonio, TX (PRWEB) July 29, 2013 -- Intrinsic Imaging, an FDA audited, ISO 9001:2008 and ISO 13485 certified medical imaging core lab... phase ii clinical trial https://www.yalemedicine.org/clinical-trials/dnaguided-second-line-adjuvant-therapy-for-high-residual-risk-stage-ii-iii-hormone-receptor-dare A Randomized Phase II Trial Of Circulating Tumor DNA-Guided Second Line Adjuvant Therapy For High... Surveillance population and ctDNA screening (up to 1000 patients): Clinically high risk, stage II-III, ER positive, HER2-, breast cancer patients who are... https://www.gsk.com/en-gb/media/press-releases/gsk-announces-positive-headline-results-from-perla-the-phase-ii-trial-of-jemperli-dostarlimab-plus-chemotherapy-in-patients-with-metastatic-non-squamous-non-small-cell-lung-cancer/ GSK announces positive headline results from PERLA, the phase II trial of Jemperli (dostarlimab)... The PERLA phase II trial is the largest global head-to-head trial of programmed death receptor-1 (PD-1) inhibitors in this population. https://www.mdpi.com/2076-393X/11/12/1767 A Phase I/II Clinical Trial of Intradermal, Controllable Self-Replicating Ribonucleic Acid Vaccine... mRNA vaccines against severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) have played a key role in reducing morbidity and mortality from coronavirus... https://www.biospace.com/capricor-therapeutics-inc-completes-enrollment-of-phase-ii-clinical-trial-for-cenderitide-to-treat-heart-failure Capricor Therapeutics, Inc. Completes Enrollment Of Phase II Clinical Trial For Cenderitide To... phase ii clinical trial https://www.biospace.com/trovagene-announces-activation-of-two-additional-clinical-trial-sites-to-conduct-its-phase-1b-2-study-of-pcm-075-in-patients-with-aml Trovagene Announces Activation of Two Additional Clinical Trial Sites to Conduct its Phase Ib/II... Feb 13, 2018 - The trial, which is being led by hematologist Jorge Cortes, M.D., Deputy Department Chair, Department of Leukemia, Division of Cancer Medicine, The University... https://menafn.com/1109525264/Biomednewsbreaks-Nanoviricides-NYSE-American-NNVC-Clears-Ethics-Review-For-Phase-II-Mpox-Trial-In-DRC Biomednewsbreaks - Nanoviricides (NYSE American: NNVC) Clears Ethics Review For Phase II Mpox Trial... Biomednewsbreaks - Nanoviricides (NYSE American: NNVC) Clears Ethics Review For Phase II Mpox Trial In DRC. NanoViricides, Inc. (NYSE American: NNVC) announced... https://www.biospace.com/phase-ii-colorectal-cancer-clinical-trial-first-to-receive-support-scientific-oversight-from-van-andel-institute-stand-up-to-cancer-epigenetics-dream Phase II Colorectal Cancer Clinical Trial First To Receive Support, Scientific Oversight From Van... https://www.biospace.com/lpath-shares-fall-80-percent-will-cut-jobs-after-second-drug-flunks-phase-ii-trial Lpath Shares Fall 80%, Will Cut Jobs After Second Drug Flunks Phase II Trial - BioSpace https://pmc.ncbi.nlm.nih.gov/articles/PMC34114/ Results of a phase-I/II randomized, masked, placebo-controlled trial of recombinant human... Interleukin-11 (IL-11) is a pleiotropic cytokine that regulates the growth and development of hematopoietic stem cells and decreases the proinflammatory... https://www.biospace.com/china-shenghuo-pharmaceutical-holdings-inc-announces-closing-of-phase-ii-clinical-trial-for-wei-dingkang-soft-capsules China Shenghuo Pharmaceutical Holdings, Inc. Announces Closing of Phase II Clinical Trial for Wei... phase ii clinical trial https://www.biospace.com/boehringer-ingelheim-and-zealand-pharma-announce-phase-ii-trial-showed-14-9-percent-weight-loss-in-people-living-with-obesity-or-overweight Boehringer Ingelheim and Zealand Pharma announce phase II trial showed 14.9% weight loss in people... May 10, 2023 - Boehringer Ingelheim and Zealand Pharma A/S announced that patients treated with BI 456906 achieved up to 14.9% weight loss after 46 weeks, using the planned... https://www.prnewswire.com/news-releases/early-safety-results-promising-for-phase-iii-trial-of-gene-therapy-treatment-of-hemophilia-b-111387439.html Early Safety Results Promising for Phase I/II Trial of Gene Therapy Treatment of Hemophilia B /PRNewswire-USNewswire/ -- Investigators report no evidence of toxicity in the four hemophilia B patients enrolled to date in a gene therapy trial using a... https://www.prnewswire.com/news-releases/gemvaxs-highly-promising-phase-ii-alzheimers-disease-clinical-trial-results-targeting-telomerase-published-in-prestigious-alzheimers-research--therapy-journal-301258354.html GemVax's highly promising Phase II Alzheimer's disease clinical trial results targeting telomerase... https://www.mdedge.com/content/phase-ii-findings-ad-drug-trial-not-all-bad Phase II Findings in AD Drug Trial 'Not All Bad' | MDedge phase ii drug trial all bad findings